Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruno Buecher

Showing results (91-100 of 115) with videos related to

Pageof 12
Sort By:
The Oncologist|February 12, 2020
Withholding the Introduction of Anti-Epidermal Growth Factor Receptor: Impact on Outcomes in RAS Wild-Type Metastatic Colorectal Tumors: A Multicenter AGEO Study (the WAIT or ACT Study)Lola-Jade Palmieri, Laurent Mineur, David Tougeron, et al.
Frontiers in Oncology|November 16, 2018
GEMO, a National Resource to Study Genetic Modifiers of Breast and Ovarian Cancer Risk in <i>BRCA1</i> and <i>BRCA2</i> Pathogenic Variant CarriersFabienne Lesueur, Noura Mebirouk, Yue Jiao, et al.
Nature Genetics|July 10, 2007
Genome-wide association scan identifies a colorectal cancer susceptibility locus on chromosome 8q24Brent W Zanke, Celia M T Greenwood, Jagadish Rangrej, et al.
Breast Cancer Research : BCR|April 19, 2018
Morphology and genomic hallmarks of breast tumours developed by ATM deleterious variant carriersAnne-Laure Renault, Noura Mebirouk, Laetitia Fuhrmann, et al.
Cancers|April 14, 2025
Screening Mammography and Breast Cancer: Variation in Risk with Rare Deleterious or Predicted Deleterious Variants in DNA Repair GenesMaximiliano Ribeiro-Guerra, Marie-Gabrielle Dondon, Séverine Eon-Marchais, et al.
International Journal of Cancer|December 28, 2020
Gene- and pathway-level analyses of iCOGS variants highlight novel signaling pathways underlying familial breast cancer susceptibilityChristine Lonjou, Séverine Eon-Marchais, Thérèse Truong, et al.
Breast Cancer Research : BCR|August 4, 2021
Diagnostic chest X-rays and breast cancer risk among women with a hereditary predisposition to breast cancer unexplained by a BRCA1 or BRCA2 mutationMaximiliano Ribeiro Guerra, Juliette Coignard, Séverine Eon-Marchais, et al.
European Journal of Human Genetics : EJHG|April 16, 2015
Clinical relevance of 8q23, 15q13 and 18q21 SNP genotyping to evaluate colorectal cancer riskStéphanie Baert-Desurmont, Françoise Charbonnier, Estelle Houivet, et al.
European Journal of Cancer (Oxford, England : 1990)|December 12, 2022
Association and performance of polygenic risk scores for breast cancer among French women presenting or not a familial predisposition to the diseaseYue Jiao, Thérèse Truong, Séverine Eon-Marchais, et al.
JNCI Cancer Spectrum|March 16, 2019
The Influence of Number and Timing of Pregnancies on Breast Cancer Risk for Women With <i>BRCA1</i> or <i>BRCA2</i> MutationsMary Beth Terry, Yuyan Liao, Karin Kast, et al.
Pageof 12

Showing results (91-100 of 115) with videos related to

Sort By:
Pageof 12
The Oncologist|February 12, 2020
Withholding the Introduction of Anti-Epidermal Growth Factor Receptor: Impact on Outcomes in RAS Wild-Type Metastatic Colorectal Tumors: A Multicenter AGEO Study (the WAIT or ACT Study)Lola-Jade Palmieri, Laurent Mineur, David Tougeron, et al.
Frontiers in Oncology|November 16, 2018
GEMO, a National Resource to Study Genetic Modifiers of Breast and Ovarian Cancer Risk in <i>BRCA1</i> and <i>BRCA2</i> Pathogenic Variant CarriersFabienne Lesueur, Noura Mebirouk, Yue Jiao, et al.
Nature Genetics|July 10, 2007
Genome-wide association scan identifies a colorectal cancer susceptibility locus on chromosome 8q24Brent W Zanke, Celia M T Greenwood, Jagadish Rangrej, et al.
Breast Cancer Research : BCR|April 19, 2018
Morphology and genomic hallmarks of breast tumours developed by ATM deleterious variant carriersAnne-Laure Renault, Noura Mebirouk, Laetitia Fuhrmann, et al.
Cancers|April 14, 2025
Screening Mammography and Breast Cancer: Variation in Risk with Rare Deleterious or Predicted Deleterious Variants in DNA Repair GenesMaximiliano Ribeiro-Guerra, Marie-Gabrielle Dondon, Séverine Eon-Marchais, et al.
International Journal of Cancer|December 28, 2020
Gene- and pathway-level analyses of iCOGS variants highlight novel signaling pathways underlying familial breast cancer susceptibilityChristine Lonjou, Séverine Eon-Marchais, Thérèse Truong, et al.
Breast Cancer Research : BCR|August 4, 2021
Diagnostic chest X-rays and breast cancer risk among women with a hereditary predisposition to breast cancer unexplained by a BRCA1 or BRCA2 mutationMaximiliano Ribeiro Guerra, Juliette Coignard, Séverine Eon-Marchais, et al.
European Journal of Human Genetics : EJHG|April 16, 2015
Clinical relevance of 8q23, 15q13 and 18q21 SNP genotyping to evaluate colorectal cancer riskStéphanie Baert-Desurmont, Françoise Charbonnier, Estelle Houivet, et al.
European Journal of Cancer (Oxford, England : 1990)|December 12, 2022
Association and performance of polygenic risk scores for breast cancer among French women presenting or not a familial predisposition to the diseaseYue Jiao, Thérèse Truong, Séverine Eon-Marchais, et al.
JNCI Cancer Spectrum|March 16, 2019
The Influence of Number and Timing of Pregnancies on Breast Cancer Risk for Women With <i>BRCA1</i> or <i>BRCA2</i> MutationsMary Beth Terry, Yuyan Liao, Karin Kast, et al.
Pageof 12